| Issue Type | Login |
|---|---|
| Country | United States |
| Industry | Login |
| Region | Login |
| Maturity Date | 2039-03-15 |
| Par Value | 2000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 240.25 |
| Coupon | 3.875 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 850.000 |
| Min. Piece | Login |
| Min. Increment | Login |
This Lilly(Eli) & Co corporate note has a 3.88% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 850.00 million USD and matures on March 15, 2039 with a last coupon date of FEB 28, 2020. |
Lilly (Eli) & Co, founded in 1876 and headquartered in Indianapolis, Indiana, is a global leader in pharmaceutical innovation dedicated to creating life-changing medicines. The company specializes in developing innovative treatments across several therapeutic areas, including oncology, diabetes, and immunology, with a commitment to improving patient outcomes.